GlassScriptPhysician profile
Charles C Nydegger
NPI 1730152745
$17,571.61
in general payments reported to CMS, 2019-2025
29 companies · $650 in 2025
The $650 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,595 · 2020: $1,992 · 2021: $2,799 · 2022: $2,071 · 2023: $751 · 2024: $6,714 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,540 · Food and Beverage: $3,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,539.65 |
| Food and Beverage | $3,576.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,650.81 | 2021-2024 | Micra, Cobalt Dr Mri Surescan, Selectsecure |
| Medtronic Vascular, INC. | $3,234.51 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $1,727.88 | 2019-2024 | Xarelto |
| Amgen INC. | $472.18 | 2020-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $422.47 | 2019-2025 | |
| Pfizer INC. | $385.36 | 2019-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $302.37 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $227.95 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $225.27 | 2019-2025 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $222.18 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $210.33 | 2019-2025 | Lokelma, Farxiga |
| Impulse Dynamics (USA) INC. | $192.62 | 2022-2024 | Optimizer |
| Abbott Laboratories | $152.40 | 2024-2025 | Merlin@Home, Gallant |
| Biotronik INC. | $152.11 | 2025 | Amvia Edge |
| Kestra Medical Technology Services, INC. | $146.73 | 2022-2023 | Assure Wcd |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $141.48 | 2021-2025 | Uptravi, Opsumit |
| Cvrx, INC. | $121.82 | 2021 | |
| Sanofi-Aventis U.S. LLC | $120.17 | 2020-2024 | |
| Philips North America LLC | $111.45 | 2022-2025 | Extended Holter, (Ck4) Mcot |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.30 | 2019-2024 | Jardiance |
| Scpharmaceuticals INC. | $61.95 | 2025 | |
| Novo Nordisk INC | $38.72 | 2022-2024 | Wegovy |
| Alnylam Pharmaceuticals INC. | $28.24 | 2025 | Onpattro |
| Baxter Healthcare | $24.45 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $22.14 | 2023 | Inpefa |
| Amarin Pharma, INC. | $19.91 | 2019 | |
| Watermark Medical, INC. | $19.55 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $19.26 | 2023 | Arcalyst |
| Bardy Diagnostics, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Nydegger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.